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Introduction and Aims 
Adding mycotoxin binders and modifiers to feed is a widespread strategy to reduce the effects of mycotoxins on animals. These products are often 
registered as technological additives and are considered safe for the animal. However, only few studies are available that investigated the interaction of 
these additives with other substances added to the feed such as cocciodiostats and veterinary drugs (Goossens et al., 2012; Osselaere et al., 2012). A large 
scale screening method is also not yet available.  
This study aims to develop and apply an in vitro model to characterize the absorptive behavior of xenobiotics in the presence of mycotoxin detoxifying 
agents and of mycotoxins. Therefore, an intestinal porcine intestinal epithelial cell line (IPEC-J2) will first be cultured on a Transwell® insert system 
(Devreese et al. 2013). Next, a mixture of veterinary active substances, together with a mycotoxin detoxifier and a mycotoxin will be applied on the 
Transwell®. The influence of twelve different detoxifiers on the cellular passage of twelve orally applied veterinary drugs in poultry and pigs, such as beta-
lactams, aminoglycosides, tetracyclines, macrolides, lincosamides, pleuromutilins, sulfonamides, trimethoprim, fluoroquinolones and sodium salicylate 
will be studied. Furthermore, nine coccidiostats including ionophoric coccidiostats, nicarbazine, halofuginone, robenidine and diclazuril, also frequently 
used in poultry and pigs, will be assessed. The mycotoxin which will be included in this study is deoxynivalenol (DON). Control groups without mycotoxin 
and/or detoxifiers will also be included. The passage of the drugs and coccidiostats will be monitored using in-house developed LC-MS² methods and the 
permeability coefficients will be compared with the control groups. To exclude drug-drug interactions, the passage characteristics of the mixture of drugs 
and cocciodiostats will be compared with the absorptive behavior of the single drug or cocciodiostat. 
Experiment 2: 
Drug interaction testing 
Experiment 1: 
Cytotoxicity testing 
Design of the third experiment: 
Xenobiotics, detoxifying agents and/or toxins are mixed and 
shaken with feed and liquid phase at pH 3.  Gradually, the mixture 
is basified, simulating the pH variation in the GI-tract of the pig. At 
each stage a sample is analyzed to assess the direct binding at 
each pH. At pH 7.8, and after an exposure time of 4 hours, an 
aliquot is transferred to the basolateral side of a Transwell® insert, 
samples are collected at regular intervals from the basolateral and 
apical side. After the experiment (4 hours exposure), the 
membrane itself is also analyzed. 
Design of the second experiment: The passage of the 
separate drugs is compared with the passage of that drug 
administered in a mixture of all drugs. The letters A, B 
and C represent different xenobiotics. 
Design of the first experiment: 
The cells are cultured in a 96-well plate for 21 
days. Next, they are exposed to various mixtures 
of the selected veterinary drugs. Toxicity will be 
assessed by a neutral red assay.  
Setup of a Transwell®-insert 
system (picture from: 
http://www.xenoblis.com) 
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Rate-of-transport-versus-concentration-gradient plots provide valuable information on 
the way of transport over the IPEC-J2 Monolayer. (adapted from: Ming Hu and Xiaoling 
Li,2011). Right: Formula for the apparent permeability Papp, ΔAr/Δt represents the rate 
of drug appearance at the receiver side, S the surface and CD,0 the initial concentration 
at the donor side 
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